AAAAAA

   
Results: 1-15 |
Results: 15

Authors: KARAKAS T MAURER U WEIDMANN E MIETHING CC HOELZER D BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Annals of oncology, 9(2), 1998, pp. 159-165

Authors: TUNCER G KARAKAS T BALKAS TI GOKCAY CF AYGNN S YURTERI C TUNCEL G
Citation: G. Tuncer et al., LAND-BASED SOURCES OF POLLUTION ALONG THE BLACK-SEA COAST OF TURKEY -CONCENTRATIONS AND ANNUAL LOADS TO THE BLACK-SEA, Marine pollution bulletin, 36(6), 1998, pp. 409-423

Authors: WEIDMANN E BRIEGER J KARAKAS T MAURER U PASCHEBERG U HOELZER D MITROU PS BERGMANN L
Citation: E. Weidmann et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW, FACTOR-INDEPENDENT ACUTEMYELOID-LEUKEMIA LINE DESIGNATED EI501, Leukemia, 11(5), 1997, pp. 709-713

Authors: BERGMANN L MIETHING C MAURER U BRIEGER J KARAKAS T WEIDMANN E HOELZER D
Citation: L. Bergmann et al., HIGH-LEVELS OF WILMS-TUMOR GENE (WT1) MESSENGER-RNA IN ACUTE MYELOID LEUKEMIAS ARE ASSOCIATED WITH A WORSE LONG-TERM OUTCOME, Blood, 90(3), 1997, pp. 1217-1225

Authors: MAURER U WEIDMANN E KRAPOHL A SCHNEIDER B KARAKAS T HOELZER D BERGMANN L
Citation: U. Maurer et al., CONSTITUTIVE EXPRESSION OF WILMS-TUMOR GENE IN K562 DOES NOT ALTER TPA-INDUCED DIFFERENTIATION, Blood, 90(10), 1997, pp. 3775-3775

Authors: KARAKAS T MAURER U WEIDMANN E HOELZER D BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 287-287

Authors: BERGMANN L KARAKAS T MIETHING CC MAURER U WEIDMANN E HOELZER D
Citation: L. Bergmann et al., THE COEXPRESSION OF BCL-2 AND WT1 MESSENGER-RNA IMPLICATES A NEW PROGNOSTIC SCORE IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 2497-2497

Authors: MAURER U WEIDMANN E KARAKAS T HOELZER D BERGMANN L
Citation: U. Maurer et al., WILMS-TUMOR GENE (WT1) MESSENGER-RNA IS EQUALLY EXPRESSED IN BLAST CELLS FROM ACUTE MYELOID-LEUKEMIA AND NORMAL CD34(+) PROGENITORS, Blood, 90(10), 1997, pp. 4230-4231

Authors: KARAKAS T BERGMANN L STUTTE HJ JAGER E KNUTH A WEIDMANN E MITROU PS HOELZER D
Citation: T. Karakas et al., PERIPHERAL T-CELL LYMPHOMAS RESPOND WELL TO VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE, PREDNISONE AND ETOPOSIDE (VACPE) AND HAVE A SIMILAR OUTCOME AS HIGH-GRADE B-CELL LYMPHOMAS, Leukemia & lymphoma, 24(1-2), 1996, pp. 121-129

Authors: KARAKAS T MIETHING CC MAURER U WEIDMANN E MITROU PS HOELZER D BERGMANN L
Citation: T. Karakas et al., THE COEXPRESSION OF BCL-2 AND WT-1 MESSENGER-RNA IN ACUTE MYELOID-LEUKEMIA PROVIDES A PROGNOSTIC INDEX FOR THE LONG-TERM OUTCOME, Experimental hematology, 24(9), 1996, pp. 551-551

Authors: BERGMANN L KARAKAS T MIETHING CC MAURER U WEIDMANN E HOELZER D
Citation: L. Bergmann et al., PROGNOSTIC INDEX FOR THE LONG-TERM OUTCOME OF ACUTE MYELOID-LEUKEMIA BASED ON THE COEXPRESSION OF BCL-2 AND WT-1 MESSENGER-RNA, Blood, 88(10), 1996, pp. 2527-2527

Authors: KARAKAS T BRIEGER J WEIDMANN E MITROU PS MELLSTEDT H HOELZER D BERGMANN L
Citation: T. Karakas et al., IL-4 INDUCED UP-REGULATION OF BCL-2 IN CLL PATIENTS IN-VIVO AND IN-VITRO, European journal of cancer, 31A, 1995, pp. 62-62

Authors: BERGMANN L KARAKAS T KNUTH A LAUTENSCHLAGER G MITROU PS HOELZER D
Citation: L. Bergmann et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER COMBINED CHEMOTHERAPY IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - A RANDOMIZED PILOT-STUDY, European journal of cancer, 31A(13-14), 1995, pp. 2164-2168

Authors: BERGMANN L KARAKAS T LAUTENSCHLAGER G JAGER E KNUTH A MITROU PS HOELZER D
Citation: L. Bergmann et al., VINCRISTINE, DOXORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE AND ETOPOSIDE (VACPE) IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - A MULTICENTER PHASE-II STUDY, Annals of oncology, 6(10), 1995, pp. 1019-1024

Authors: KARAKAS T BRIEGER J WEIDMANN E MITROU PS MELLSTEDT H HOELZER D BERGMANN L
Citation: T. Karakas et al., UP-REGULATION OF BCL-2 IN CLL PATIENTS BY IL-4 IN-VIVO AND IN-VITRO, Experimental hematology, 23(8), 1995, pp. 933-933
Risultati: 1-15 |